Dr. Kong's favorite peptides list needs more context

What does this video actually claim?

Dr. Joy Kong lists her four favorite peptides on Instagram: BPC-157, TB-500, Epitalon, and Ipamorelin. She describes these as great starter peptides and ones she uses personally, then promotes her clinic's peptide services.

The post doesn't make specific health claims about what these peptides do. It's essentially a product recommendation with a sales pitch attached. But the implication is clear: these are safe, effective compounds worth trying.

What's the regulatory status of these peptides?

None of these four peptides are FDA-approved drugs. The FDA has specifically warned multiple times about compounded peptides being sold without proper oversight.

BPC-157 and TB-500 exist in a regulatory gray area. They're sold as "research chemicals" but marketed for human use. Epitalon has virtually no human clinical data. Only Ipamorelin has been studied in actual clinical trials, though those trials were for specific medical conditions, not general wellness.

The FDA sent warning letters to companies selling these compounds in 2022 and 2023. They're concerned about safety, purity, and unproven claims.

What does the science actually show?

The evidence is thin across the board. BPC-157 has some promising animal studies for tissue repair, but zero published human trials. TB-500 (thymosin beta-4) has limited human data, mostly in small wound healing studies.

Epitalon is the weakest link here. It's based on research by Vladimir Khavinson, but there are no peer-reviewed human studies showing it works for anything. The longevity claims come from unpublished presentations and animal work.

Ipamorelin stimulates growth hormone release and was studied in trials for postoperative recovery. But those studies used specific dosing protocols under medical supervision, not the general wellness approach most peptide clinics use.

What are the real risks here?

Quality control is the biggest concern with compounded peptides. You're trusting that your clinic's supplier got the peptide purity right, stored it properly, and mixed it correctly.

A 2023 analysis found that many peptide products contained different amounts than labeled. Some had bacterial contamination. Others had degradation products that could be harmful.

Then there's the injection risk. These are typically given subcutaneously, which carries infection risks if not done properly. Dr. Kong's post doesn't mention any of these safety considerations.

What should you actually know?

Peptide therapy isn't inherently bogus, but it's not ready for mainstream use either. The field needs more human studies, better quality control, and clearer regulatory oversight.

If you're considering peptides, work with a physician who understands the limitations. They should discuss the lack of FDA approval, potential risks, and realistic expectations about benefits.

Dr. Kong's list reads more like marketing than medical guidance. A responsible approach would include discussing the evidence gaps and regulatory status, not just promoting favorites.